Patents by Inventor Keith Harding

Keith Harding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patch comprising potassium permanganate for the treatment of skin disorder
    Patent number: 11129800
    Abstract: The invention relates to medical treatment patch, ideally for applying topically, that permits the targeted, sustained and controlled release of potassium KMnO4; and a method of treating a skin disorder comprising applying said patch.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: September 28, 2021
    Assignee: NEEM BIOTECH LTD
    Inventors: David Houston, Keith Harding, Charles Heard
  • PATCH COMPRISING POTASSIUM PERMANGANATE FOR THE TREATMENT OF SKIN DISORDER
    Publication number: 20190224133
    Abstract: The invention relates to medical treatment patch, ideally for applying topically, that permits the targeted, sustained and controlled release of potassium KMnO4; and a method of treating a skin disorder comprising applying said patch.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 25, 2019
    Applicant: NEEM BIOTECH LTD
    Inventors: David HOUSTON, Keith HARDING, Charles HEARD
  • Molecular targets for healing or treating wounds
    Patent number: 9782381
    Abstract: Molecular target for healing or treating wounds and, in particular chronic, human wounds, are described. The molecular target is PTPRK, or a protein 50% homologous therewith, and which retains the same activity as PTPRK protein. Further, methods and novel therapeutics are described for treating said wounds.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: October 10, 2017
    Assignee: University College Cardiff Consultants Limited
    Inventors: Wenguo Jiang, Keith Harding
  • MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
    Publication number: 20160331716
    Abstract: Molecular target for healing or treating wounds and, in particular chronic, human wounds, are described. The molecular target is PTPRK, or a protein 50% homologous therewith, and which retains the same activity as PTPRK protein. Further, methods and novel therapeutics are described for treating said wounds.
    Type: Application
    Filed: May 9, 2016
    Publication date: November 17, 2016
    Inventors: Wenguo Jiang, Keith Harding
  • MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
    Publication number: 20160038563
    Abstract: The invention relates to at least one molecular target for healing or treating wounds and, in particular chronic, human wounds. The molecular target is nWASP or a protein at least 75% homologous therewith and which retains the same activity as nWASP protein, such as WASP. Further, the invention concerns a novel therapeutic for treating said wounds and a novel gene therapy approach, involving said molecular target, for treating said wounds.
    Type: Application
    Filed: June 26, 2015
    Publication date: February 11, 2016
    Inventors: Keith Harding, Wen Guo Jiang
  • MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
    Publication number: 20140213629
    Abstract: The invention relates to at least one molecular target for healing or treating wounds and, in particular chronic, human wounds. The molecular target is PTPRK, or a protein 50% homologous therewith, and which retains the same activity as PTPRK protein. Further, the invention concerns a novel therapeutic for treating said wounds and a novel gene therapy approach, involving said molecular target, for treating said wounds.
    Type: Application
    Filed: February 17, 2012
    Publication date: July 31, 2014
    Applicant: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Wenguo Jiang, Keith Harding
  • METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF WOUNDS
    Publication number: 20130116134
    Abstract: The invention relates to a method and kit for identifying chronic or acute mammalian wound tissue or for determining the prognosis of mammalian wound tissue based upon the identification of at least one key set of molecular markers or genes whose expression pattern is indicative of a given wound type and so representative of a given prognosis.
    Type: Application
    Filed: September 8, 2010
    Publication date: May 9, 2013
    Applicant: University College Cardiff Consultants Limited
    Inventors: Wenguo Jiang, Keith Harding
  • MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS
    Publication number: 20120321613
    Abstract: The invention relates to at least one molecular target for healing or treating wounds and, in particular chronic, human wounds. The molecular target is nWASP or a protein 50% homolgous therewith and which retains the same activity as nWASP protein, such as WASP. Further, the invention concerns a novel therapeutic for treating said wounds and a novel gene therapy approach, involving said molecular target, for treating said wounds.
    Type: Application
    Filed: February 16, 2011
    Publication date: December 20, 2012
    Applicant: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Keith Harding, Wen Guo Jiang